Population pharmacokinetic—pharmacodynamic modeling of ketamine‐induced pain relief of chronic pain
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Aims: Pharmacological treatment of chronic (neuropathic) pain is often disappointing. In order to enhance our insight in the complex interaction between analgesic drug and chronic pain relief, we performed a pharmacokinetic—pharmacodynamic (PK—PD) modeling study on the effect of S(+)‐ketamine on pain scores in Complex Regional Pain Syndrome type 1 (CRPS‐1) patients. Methods: Sixty CRPS‐1 patients were randomly allocated to received a 100‐h infusion of S(+)‐ketamine or placebo. The drug infusion rate was slowly increased from 5 mg/h (per 70 kg) to 20 mg/h based upon the effect/side effect profile. Pain scores and drug blood samples were obtained during the treatment phase and pain scores were further obtained weekly for another 11 weeks. A population PK—PD model was developed to analyze the S(+)‐ketamine‐pain data. Results: Plasma concentrations of S(+)‐ketamine and its metabolite decreased rapidly upon the termination of S(+)‐ketamine infusion. The chance for an analgesic effect from ketamine and placebo treatment was 67±10% and 23±9% (population value±SE), respectively. The pain data were well described by the PK—PD model with parameters C50=10.5±4.8 ng/ml (95% ci 4.37–21.2 ng/ml) and t ½ for onset/offset=10.9±4.0 days (5.3–20.5 days). Discussion: Long‐term S(+)‐ketamine treatment is effective in causing pain relief in CRPS‐1 patients with analgesia outlasting the treatment period by 50 days. These data suggest that ketamine initiated a cascade of events, including desensitization of excitatory receptor systems in the central nervous system, which persisted but slowly abated when ketamine molecules were no longer present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amanzio, M., & Benedetti, F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00484.1999 · Cited by 899
Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man
Schüttler, J., Stanski, D. R., White, P. F., Trevor, A. J., Horai, Y., Verotta, D., & Sheiner, L. B. (1987) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01066320 · Cited by 178
Investigating the pharmacodynamics of ketamine in children
HERD, D. W., ANDERSON, B. J., KEENE, N. A., & HOLFORD, N. H. G. (2008) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2007.02384.x · Cited by 103 · cited 2×
“In acute pain and anesthesia studies the value of t1⁄2kE0 has values <1 min (Schüttler et al., 1987; Herd et al., 2008; Sigtermans et al., 2009b), indicating that these end-points are driven by ketamine’s pharmacokinetics with little or no delay between plasma and effect-site concentrations (and consequently effect).”
Background
Cited by
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., & Saari, T. I. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0383-6 · Cited by 672
Ketamine for chronic pain: risks and benefits
Niesters, M., Martini, C., & Dahan, A. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12094 · Cited by 508
Self-citationKetamine – More mechanisms of action than just NMDA blockade
Sleigh, J., Harvey, M., Voss, L., & Denny, B. (2014) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2014.03.002 · Cited by 434
Zhao, X., Venkata, S. L. V., Moaddel, R., Luckenbaugh, D. A., Brutsche, N. E., Ibrahim, L., Zarate Jr, C. A., Mager, D. E., & Wainer, I. W. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04198.x · Cited by 137
Zorumski, C. F., Nagele, P., Mennerick, S., & Conway, C. R. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00172 · Cited by 57
“(42) infused ketamine at a dose of 5–20 mg/h for 100 h.”
Background
Metadata
- Authors
- Dahanl, A., Olofsenl, E., Sigtermans, M., Noppers, I., Niesters, M., Aarts, L., Bauer, M., & Sarton, E.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2011-03
- Volume
- 15
- Issue
- 3
- Pages
- 258-267
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W2098358567
- Cited by
- 119
- References
- 3
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.